Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Pediatr. 2018 Jun 29;201:221–228.e16. doi: 10.1016/j.jpeds.2018.05.019

FIGURE 2. Interval Hydroxyurea Use in Q-SHIP Participants and Non-Participants During Follow-Up.

FIGURE 2

Hydroxyurea initiation in Q-SHIP participants and non-participants over time. Twelve weeks from ED presentation, Q-SHIP participants were significantly more likely to start hydroxyurea than non-participants (35/66 participants versus 9/46 non-participants, p=0.0004). At the study’s conclusion, significantly more Q-SHIP participants were taking hydroxyurea than non-participants (33/66 participants versus 9/46 non-participants, p=0.001).